Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского», Москва, Россия palantirr@inbox.ru
Список исп. литературыСкрыть список 1. American Diabetes Association 2. Classification and Diagnosis of Diabetes. Diabetes Care 2020; 43 (Suppl. 1): S14–31. DOI: 10.2337/dc20-S002 2. International Diabetes Federation IDF Diabetes Atlas 9th Edition. IDF Diabetes Atlas. 2020. Available at: https://www.diabetesatlas.org/en/ resources/ (Accessed 02.11.2023) 3. World Health Organization Diabetes. https://www.who.int. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes (Accessed 02.11.2023) 4. American Diabetes Association 7. Diabetes technology: standards of medical care in diabetes-2020. Diabetes Care 2020; 43 (Suppl. 1): S77–88. DOI: 10.2337/dc20-S007 5. Tchero H, Kangambega P, Briatte C et al. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health 2019; 25 (7): 569–83. DOI: 10.1089/tmj.2018.0128 6. WHO Global Observatory for eHealth. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth. Geneva: World Health Organization, 2010. 7. American Telemedicine Association (ATA) Telehealth: Defining 21st Century Care. Telehealth Basics – ATA. 2019. Available at: https://www.americantelemed.org/resource/why-telemedicine/ (Accessed 02.11.2023) 8. Unsworth H, Dillon B, Collinson L et al. The NICE Evidence Standards Framework for digital health and care technologies – Developing and maintaining an innovative evidence framework with global impact. Digit Health 2021; 7: 20552076211018617. DOI: 10.1177/2055207 6211018617. 9. Tan SY, Wong JL, Sim YJ et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr 2019; 13 (1): 364–72. DOI: 10.1016/j.dsx.2018.10.008 10. Faruque LI, Wiebe N, Ehteshami-Afshar A et al, Alberta Kidney Disease Network. Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. Can Med Assoc J 2017; 189 (9): E341–64. DOI: 10.1503/cmaj.150885 11. Hu Y, Wen X, Wang F et al. Effect of telemedicine intervention on hypoglycaemia in diabetes patients: a systematic review and meta-analysis of randomised controlled trials. J Telemed Telecare 2019; 25 (7): 402–13. DOI: 10.1177/1357633X18776823 12. Marcolino MS, Maia JX, Alkmim MB et al. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One 2013; 8 (11): e79246. DOI: 10.1371/journal.pone.0079246 13. Polisena J, Tran K, Cimon K et al. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab 2009; 11 (10): 913–30. DOI: 10.1111/j.1463-1326.2009.01057.x 14. So CF, Chung JW. Telehealth for diabetes self-management in primary healthcare: a systematic review and meta-analysis. J Telemed Telecare 2018; 24 (5): 356–64. DOI: 10.1177/1357633X17700552 15. Su D, Zhou J, Kelley MS et al. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract 2016; 116: 136–48. DOI: 10.1016/j.diabres.2016.04.019 16. Toma T, Athanasiou T, Harling L et al. Online social networking services in the management of patients with diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Pract 2014; 106 (2): 200–11. DOI: 10.1016/j.diabres.2014.06. 008 17. Lee SW, Chan CK, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep 2017; 7 (1): 12680. DOI: 10.1038/s41598-017-12987-z 18. Predieri B, Leo F, Candia F et al. Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol 2020; 11: 965. DOI: 10.3389/fendo.2020.595735 19. Wu C, Wu Z, Yang L et al. Evaluation of the clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2018; 97 (43): e12962. DOI: 10.1097/MD. 0000000000012962 20. Tao D, Or CK. Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials. J Telemed Telecare 2013; 19 (3): 133–43. DOI: 10.1177/1357633X13479701 21. Baron J, McBain H, Newman S. The impact of mobile monitoring technologies on glycosylated hemoglobin in diabetes: a systematic review. J Diabetes Sci Technol 2012; 6 (5): 1185–96. DOI: 10.1177/ 193229681200600524 22. De Jong CC, Ros WJ, Schrijvers G. The effects on health behavior and health outcomes of Internet-based asynchronous communication between health providers and patients with a chronic condition: a systematic review. J Med Internet Res 2014; 16 (1): e19. DOI: 10.2196/jmir.3000 23. Lee JY, Lee SW. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018; 20 (7): 492–500. DOI: 10.1089/dia.2018.0098 24. Walker CL, Kopp M, Binford RM, Bowers CJ. Home telehealth interventions for older adults with diabetes. Home Healthc Now 2017; 35 (4): 202–10. DOI: 10.1097/NHH.0000000000000522 25. Siriwardena LS, Wickramasinghe WA, Perera KL et al. A review of telemedicine interventions in diabetes care. J Telemed Telecare 2012; 18 (3): 164–8. DOI: 10.1258/jtt.2012.SFT110